cbdMD (YCBD) Restructuring Costs (2022)

cbdMD (YCBD) reported Restructuring Costs of $602092.0 for Q2 2022.

cbdMD (YCBD) Restructuring Costs (2022) Analysis & Trends

cbdMD (YCBD) has 1 years of Restructuring Costs data on file, last reported at $602092.0 in Q2 2022.

For the quarter ending Q2 2022, Restructuring Costs changed N/A year-over-year to $602092.0; the trailing twelve-month figure through Sep 2023 stood at $602092.0 (changed 0.0% YoY), and the FY2022 full-year result was $602092.0, changed N/A from the prior year.
Restructuring Costs steadied at $602092.0 in Q2 2022.
In the past five years, Restructuring Costs ranged from a high of $602092.0 in Q2 2022 to a low of $602092.0 in Q2 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	cbdMD	438,678.80	-2.95 Mn	3.00 Mn

Historic Data

Download Data

Date	Value
Jun 30, 2022	602,092.00